PAVmed, Inc. (PAVM)
4.96
-0.02
(-0.40%)
USD |
NASDAQ |
Jun 11, 10:56
PAVmed Total Liabilities (Quarterly) : 20.43M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 20.43M |
| December 31, 2025 | 16.51M |
| September 30, 2025 | 12.28M |
| June 30, 2025 | 12.47M |
| March 31, 2025 | 11.89M |
| December 31, 2024 | 37.69M |
| September 30, 2024 | 39.94M |
| June 30, 2024 | 58.06M |
| March 31, 2024 | 57.83M |
| December 31, 2023 | 57.14M |
| September 30, 2023 | 57.85M |
| June 30, 2023 | 54.51M |
| March 31, 2023 | 54.48M |
| December 31, 2022 | 43.05M |
| September 30, 2022 | 43.91M |
| June 30, 2022 | 41.05M |
| March 31, 2022 | 19.60M |
| December 31, 2021 | 7.558M |
| September 30, 2021 | 7.751M |
| June 30, 2021 | 5.331M |
| March 31, 2021 | 3.329M |
| December 31, 2020 | 20.25M |
| September 30, 2020 | 25.26M |
| Date | Value |
|---|---|
| June 30, 2020 | 21.69M |
| March 31, 2020 | 26.34M |
| December 31, 2019 | 11.88M |
| September 30, 2019 | 6.812M |
| June 30, 2019 | 8.940M |
| March 31, 2019 | 10.02M |
| December 31, 2018 | 10.97M |
| September 30, 2018 | 5.835M |
| June 30, 2018 | 4.715M |
| March 31, 2018 | 3.511M |
| December 31, 2017 | 4.488M |
| September 30, 2017 | 9.146M |
| June 30, 2017 | 5.276M |
| March 31, 2017 | 5.409M |
| December 31, 2016 | 1.190M |
| September 30, 2016 | 0.8422M |
| June 30, 2016 | 0.4033M |
| March 31, 2016 | 0.8443M |
| December 31, 2015 | 0.5802M |
| September 30, 2015 | 0.2385M |
| June 30, 2015 | 0.0852M |
| March 31, 2015 | 0.0423M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lucid Diagnostics, Inc. | 30.08M |
| Alphatec Holdings, Inc. | 781.22M |
| SINTX Technologies, Inc. | 6.907M |
| PROCEPT BioRobotics Corp. | 139.40M |
| Abbott Laboratories | 57.73B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.42M |
| Shareholders Equity (Quarterly) | 39.52M |
| Debt to Equity Ratio | 0.4304 |
| Current Ratio | 2.024 |
| Net Debt Paydown Yield | 31.76% |